Forum

Notifications

Clear all

Changing from Tirz to Sema

GENERAL DISCUSSION

Last Post by Admin 2 years ago

2 Posts

2 Users

0 Reactions

804 Views

RSS

Posts: 2

Cantweight

Topic starter

Mar 24, 2024 7:36 pm

(@cantweight)

Active Member

Joined: 2 years ago

Hey there everyone I’m new to this group but have a huge appreciation for all of the research that has been shared! This is amazing.

Does anyone have experience transitioning from Tirz to Sema? Due to the cost, I’m going to need to change over to Sema but unsure what dose I should start with. I just took my 2nd 7.5mg injection of Tirz. Do I need to start at the lowest dose of Sema?

1 Reply

Share:

4 Forums
203 Topics
1,639 Posts
0 Online
7,998 Members

Forum Icons: Forum contains no unread posts Forum contains unread posts

Topic Icons: Not Replied Replied Active Hot Sticky Unapproved Solved Private Closed

Powered by wpForo Powered by wpForo version 2.4.13

Your IP Address: 216.73.217.48

HOW TO RECONSTITUTE PEPTIDES

INFORMATION:

Semaglutide and Weight Loss: Insights from Animal Studies (Rodents, 2020)
Introduction Obesity remains a global health concern, leading researchers to explore innovative approaches for weight management. Among these approaches, the study titled “Semaglutide… Read more: Semaglutide and Weight Loss: Insights from Animal Studies (Rodents, 2020)
Selank Study: Pioneering a Pathway to Stress Resilience and Cognitive Enhancement
Introduction In an ever-demanding world, stress and cognitive challenges have become pervasive issues. The study titled “Selank Ameliorates the Depression-like Behaviors and Cognitive… Read more: Selank Study: Pioneering a Pathway to Stress Resilience and Cognitive Enhancement
Melanotan II Study: A Glimpse of Hope in Reversing Autistic Traits
Introduction The pursuit of innovative treatments for Autism Spectrum Disorder (ASD) continues to be a priority in medical research. In this endeavor, the… Read more: Melanotan II Study: A Glimpse of Hope in Reversing Autistic Traits
BPC 157 study into Glaucoma and Other Ocular Conditions
Introduction In the realm of ocular health, researchers have long sought innovative therapies to address conditions such as glaucoma and other ocular disorders.… Read more: BPC 157 study into Glaucoma and Other Ocular Conditions
Unveiling the Potential of Thymosin Beta-4 (TB-500) in Alzheimer’s Disease Therapy
Introduction In the landscape of medical research, the pursuit of innovative treatments for neurodegenerative diseases remains a challenge that drives scientific exploration. Among… Read more: Unveiling the Potential of Thymosin Beta-4 (TB-500) in Alzheimer’s Disease Therapy